Søgning
Søgning på udtrykket 'covid' giver 53 resultater
Dokumenter [9] Sider [3] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [9]
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Denne vejledning er tiltænkt diagnostik og behandling af COVID-19. Denne retningslinje vil løbende blive opdateret, som ny evidens kommer frem. Ændringer siden version 29: Indikationer for COVID-19 test er tilføjet.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Invitation til møde den 20. maj 2022
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo.
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne.
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid.
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
30.04.2025
. Background. The management of many chronic diseases requires a multidisciplinary and holistic approach. Long Covid is a recent, poorly understood disease with several symptoms. Most recommendations suggest a multidisciplinary approach. While there are a few programs aimed to the management of Long Covid, to our knowledge very few were assessed.
BMC Infectious Diseases
30.04.2025
. Background. Sepsis is a serious medical condition that causes long-term morbidity and high mortality, annually affecting millions of people worldwide. The COVID-19 pandemic may have impacted its burden. This study aimed to estimate the impact of the COVID-19 pandemic on sepsis incidence, etiology and associated hospitalization costs in metropolitan France. . Methods.
BMC Infectious Diseases
30.04.2025
. Background. Coronavirus disease 2019 (COVID-19) have posed a great threat to human health. We carried out this systematic review and meta-analysis for two objectives. First, to evaluate the differences in lung infection between the Omicron variants and the non-Omicron strains by chest computed tomography (CT); second, to evaluate the differences in chest CT features between COVID-19 patients with the Omicron variants and those with non-Omicron strains in CT-positive cases.
BMC Infectious Diseases
30.04.2025
. Background. Post COVID-19 condition (PCC) affects 10–40% of patients and is characterized by persisting symptoms at ≥ 4 weeks after SARS-CoV-2 infection. Symptoms can last 7 or even more months. How long PCC persists and any changes in its clinical phenotypes over time require further investigation. We investigated PCC trajectories and factors associated with PCC persistence. . Material and methods.
PLoS One Infectious Diseases
29.04.2025
by Hyunmin Yu, Stephen Bonett, Ufuoma Oyiborhoro, Subhash Aryal, Andrew Kim, Melanie L. Kornides, John B. Jemmott, Karen Glanz, Antonia M. Villarruel, José A. Bauermeister .
PLoS One Infectious Diseases
29.04.2025
…rd the majority of human mobility patterns in real-time. Bolstered by the rapid expansion of telecommunication networks and the ubiquitous use of smartphones, mobile phone network data (MPND) played a pivotal role in fighting and controlling the spread of COVID-19.
Clinical Microbiology and Infection
29.04.2025
During the coronavirus disease 2019 (COVID-19) pandemic, real-world data and observational studies played an important role in assessing treatment effectiveness. Methodological challenges such as immortal time bias, confounding, and competing risks were observed. Target trial emulation provides a structured framework for evaluating treatment effectiveness using observational data while mitigating these biases.
BMC Infectious Diseases
29.04.2025
Immunocompromised (IC) patients face significant challenges in managing COVID-19 due to their heightened susceptibility to severe illness, persistent infections, and the potential development of drug resistance. Studies indicate that IC patients, particularly those with hematologic malignancies (HM), hematopoietic stem cell transplants (HSCTR), or solid organ transplants (SOTR), experience higher mortality rates and worse outcomes compared to the general population, even post-vaccination.
PLoS One Infectious Diseases
28.04.2025
by Mahsa Motiei, Afagh Hassanzadeh Rad, Hamidreza Badeli, Reza Bayat . Objectives To find the pattern of hospitalization pattern change in COVID-19 pandemic, we aimed to compare the admission and mortality rate of each disease in all wards before and during the pandemic. Methods Data for all ICD-10 disease categories were collected from 17 shahrivar hospital database for 14922 patients before (23 July 2017–23 January 2020 (and 10941 patients during the pandemic (20 February 2020- 20 September 2022).
BMC Infectious Diseases
27.04.2025
. Purpose. The COVID-19 pandemic has led to the emergence of a secondary public health crisis known as Long COVID. It is estimated that approximately 10% of individuals who contact COVID-19 develop Long COVID, with fatigue and brain fog being among the most commonly reported and debilitating symptoms. However, no standardized or effective treatments are currently available.
Journal of Infectious Diseases
26.04.2025
Abstract . Background . Post-COVID syndrome (PCS) is characterized by persistent symptoms lasting beyond 12 weeks after SARS-CoV-2 infection. The underlying pathomechanims remain poorly understood.Methods . We conducted detailed immunological analyses in 47 individuals with PCS, assessed >12 weeks post-acute SARS-CoV-2 infection, and compared them to 25 convalescent controls without symptoms.
BMJ Open
26.04.2025
. Background. Long covid describes a syndrome of persistent symptoms following COVID-19 and is responsible for substantial healthcare and economic burden. Currently, no effective treatments have been established. Ashwagandha (Withania somnifera (L.) Dunal) is a medicinal herb traditionally used in India for its immune-strengthening and anti-inflammatory properties.
BMC Infectious Diseases
26.04.2025
. Introduction. Long COVID is a multisystemic, fluctuating condition inducing a high burden on affected people. Despite the existence of some guidelines, its management remains complicated. We aimed to demonstrate that symptoms after a COVID-19 infection evolve following different trajectories from the initial infection until 24 months after, to identify the determinants of these trajectories, and the quality of life of people in these trajectories. .
BMC Infectious Diseases
26.04.2025
. Background. In the Netherlands, a low COVID-19 vaccination uptake was reported among Moroccan immigrants. This population also faced a higher risk of contracting COVID-19, as well as severe morbidity and mortality, compared to native Dutch. We aimed to explore the COVID-19 vaccination decision-making process and the process from vaccination intention to uptake among Moroccan immigrants in the Netherlands. . Methods.
PLoS One Infectious Diseases
26.04.2025
by Theodore J. Witek, Jr., Natasha Yasmin Sheikhan, Allan Tran . Objective To evaluate the sensory impacts of COVID-19 infection among wine professionals, and consequences on personal and professional well-being. Our goal was to better understand these effects on an occupational cohort who relies heavily on intact sensory function.
PLoS One Infectious Diseases
26.04.2025
…ai, Camilla Tincati, Emerenziana Ottaviano, Silvia Ancona, Giulia Marchetti, Elisa Borghi . Background Anti-SARS-CoV-2 neutralizing monoclonal antibodies (mAbs) have been shown to have clinical benefits in treating high-risk patients with mild-moderate COVID-19. SARS-CoV-2 RNA in serum (RNAemia), is usually associated with severe disease and deaths.
Journal of Medical Virology
25.04.2025
Journal of Medical Virology, Volume 97, Issue 5, May 2025.
Critical Care Explorations
25.04.2025
… injury biomarkers—club cell secretory protein (CC16), surfactant protein D (SPD), surfactant protein A (SPA), and receptor for advanced glycation end-products (RAGE)—could prognosticate disease severity and predict treatment responses in hospitalized COVID-19 patients receiving fostamatinib. DESIGN: . Retrospective analysis of samples collected from a randomized, placebo-controlled clinical trial evaluating the safety and efficacy of fostamatinib in hospitalized COVID-19 patients. SETTING: .
BMC Infectious Diseases
25.04.2025
…ital in Wrocław, Poland, from January 1, 2020, to June 30, 2024, and included 2,751 patients. The aim was to evaluate the incidence, epidemiological, and microbiological characteristics, mortality rates, and prevention strategies of UTIs during and after COVID-19 pandemic. . Results. Catheter-Associated Urinary Tract Infection (CAUTI) (48 hours after admission) was recorded in 243/2751 (8.83%) patients, whereas UTI at admission was found in 63/2751 (2.3%).
PLoS One Infectious Diseases
25.04.2025
… Sérgio Renato da Rosa Decker, Regis Goulart Rosa, Maicon Falavigna . The novel coronavirus (SARS-CoV-2) has caused a significant impact in Brazil, with over 37 million cases and 690,000 deaths. Survivors often experience prolonged symptoms, termed post-COVID-19 condition or long COVID, affecting various aspects of life. Data on post-COVID-19 in Brazil, particularly amid the Omicron variant, are limited.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
Medscape Infectious Diseases
30.04.2025
Pope Francis’ health crisis highlights the delicate balance between transparency and privacy, particularly if COVID-19 had been involved and the global reaction it could have provoked. . Medscape UK
Medscape Infectious Diseases
29.04.2025
The nasal vaccine, tested on animals since 2021, may offer a new tool in fighting COVID-19 with a non-invasive, easy-to-administer solution. . Medscape News UK
Statens Serum Institut
25.04.2025
Nyt dansk studie viser, at de opdaterede covid-19-vacciner fortsat beskytter effektivt mod alvorlig sygdom og død – også over for nye virusvarianter.
Morbidity and Mortality Weekly Report (MMWR)
25.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
Medscape Infectious Diseases
25.04.2025
Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert. . Reuters Health Information
Medscape Infectious Diseases
21.04.2025
Better diagnostics, more focused treatment, and deeper understanding of individualized symptoms could all take major steps forward this year. . Medscape Medical News
Medscape Infectious Diseases
14.04.2025
In patients hospitalised for COVID-19, fatigue, memory and cognitive problems worsened between years 2 and 3 post-discharge; nearly one third of patients developed PEM at 3 years, a study finds. . Medscape News UK
ProMED
13.04.2025
…ttp://www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . Date: Thu 10 Apr 2025 . Source: CIDRAP (Center for Infectious Disease Research & Policy). [edited] . www.cidrap.umn.edu/covid-19/using-study-design-past-researchers-again-show-covid-19-airborne . . . In 1959, researchers built a facility near Pretoria, South Africa, to. study the airborne route of tuberculosis transmission, replicating an.
Medscape Infectious Diseases
8.04.2025
NIH cuts target $1.6 billion RECOVER initiative to study and improve treatment of long COVID, putting further research gains in doubt. . Medscape Medical News
Medscape Infectious Diseases
8.04.2025
New research links multisystem inflammatory syndrome in children with COVID-19 to Epstein-Barr virus reactivation, revealing immune dysfunction and potential treatment targets. . Medscape Medical News
Medscape Infectious Diseases
4.04.2025
The U.S. Food and Drug Administration has missed its deadline for making a decision on traditional approval for Novavax's COVID-19 vaccine, the company told Reuters on. . Reuters Health Information
ProMED
2.04.2025
…******************************************************. A ProMED-mail post. www.promedmail.org. ProMED-mail is a program of the. International Society for Infectious Diseases. www.isid.org . In this update: . [1] Russia: Publication of daily COVID-19 reports halted . [2] Macau: COVID-19 positive rate at 40%; 2 health bureaus urge. vaccination . [3] Hong Kong: Local influenza activity continues to decline, COVID-19. activity begins to rise slightly .
Morbidity and Mortality Weekly Report (MMWR)
1.04.2025
COVID-19 vaccine effectiveness against hospitalizations was stable, but it declined against new infections among adults in New York during May-July 2021.
ECDC COVID-19 updates
26.03.2025
COVID-19 vaccination reduced the risk of developing ‘long COVID’ by approximately 27% in adults fully vaccinated before infection, according to a literature review carried out by the European Centre for Disease Prevention and Control (ECDC).
ECDC COVID-19 updates
26.03.2025
This report addresses whether COVID-19 vaccination also reduces the risk and/or duration of a wide range of post-acute COVID-19 symptoms, commonly referred to as ‘long COVID’.
ECDC COVID-19 updates
22.03.2025
ECDC is supporting a large number of targeted External Quality Assessment (EQA) schemes with voluntary participation by reference or primary laboratories, which are active members of EU surveillance networks.
Medscape Infectious Diseases
19.03.2025
After COVID-19, RSV cases appear earlier and result in more severe illness in infants, with increased oxygen and ventilation needs, a new study reports. . Medscape News UK
Medscape Infectious Diseases
14.03.2025
Daily oral drug reduced COVID-19 risk by 67% in exposed but uninfected adults . Medscape Medical News
Medscape Infectious Diseases
14.03.2025
Measles cases in the European region doubled in 2024 to a more than 25-year-high, the World Health Organisation and UNICEF said on Thursday, as they urged action to restore. . Reuters Health Information
Eurosurveillance latest updates
14.03.2025
. Background. Evolution of SARS-CoV-2 is continuous. . . Aim. Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. . . Methods. In nasopharyngeal swabs of COVID-19 patients (n = 1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined.